Search This Blog

Tuesday, January 29, 2019

Allergan sees Q1 adjusted EPS $3.40-$3.60, consensus $3.75


Sees Q1 revenue $3.4B-$3.55B, consensus $3.65B.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.